Clinical Validation of a Blood-Based Predictive Test for Stratification of Response to Tumor Necrosis Factor Inhibitor Therapies in Rheumatoid Arthritis Patients
Theodore Mellors(BG Medicine (United States)), Viatcheslav R. Akmaev, Susan Dina Ghiassian(Boston Engineering (United States)), Joel M. Kremer(Research Foundation for the State University of New York), Mengran Wang(BG Medicine (United States)), Feixiong Cheng(Cleveland Clinic Lerner College of Medicine), Marc Santolini(University of Genoa), Keith Johnson(Brigham and Women's Hospital), Jeffery R. Curtis(University of Alabama at Birmingham), Asher Ameli(Northeastern University), Johanna B. Withers(BG Medicine (United States)), Dimitrios A. Pappas(NewYork–Presbyterian Hospital), Ítalo Faria do Valle(Institut Gustave Roussy), Helia N. Sanchez(BG Medicine (United States)), Lixia Zhang(BG Medicine (United States)), Michael Sebek(Northeastern University), Alif Saleh(BG Medicine (United States)), Alex Jones(BG Medicine (United States))
Cited by 42
Related Papers
2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
|Arthritis Care & Research|2012|1.8k
A Proteome-Scale Map of the Human Interactome Network
|Cell|2014|1.5k
Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19
|PubMed Central|2020|528